Strs Ohio Purchases New Shares in Teleflex Incorporated $TFX

Key Points

• Strs Ohio has acquired 22,000 shares of Teleflex Incorporated, valued at approximately $3,040,000, in the first quarter, reflecting growing institutional interest in the company.
• Teleflex reported a quarterly EPS of $3.73, exceeding estimates and signifying a year-over-year revenue increase of 4.2% to $780.90 million.
• The company recently declared a $0.34 quarterly dividend, with an annualized yield of 1.1% and a payout ratio of 32%.

Strs Ohio bought a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 22,000 shares of the medical technology company's stock, valued at approximately $3,040,000.

Several other hedge funds and other institutional investors have also made changes to their positions in TFX. Ameriprise Financial Inc. raised its stake in shares of Teleflex by 62.4% in the fourth quarter. Ameriprise Financial Inc. now owns 23,660 shares of the medical technology company's stock valued at $4,211,000 after acquiring an additional 9,094 shares during the period. Lazard Asset Management LLC raised its stake in shares of Teleflex by 9,420.0% in the fourth quarter. Lazard Asset Management LLC now owns 476 shares of the medical technology company's stock valued at $84,000 after acquiring an additional 471 shares during the period. OMERS ADMINISTRATION Corp raised its stake in shares of Teleflex by 20.3% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,957 shares of the medical technology company's stock valued at $348,000 after acquiring an additional 330 shares during the period. Nomura Holdings Inc. purchased a new stake in shares of Teleflex in the fourth quarter valued at $273,000. Finally, ProShare Advisors LLC increased its stake in Teleflex by 6.4% in the 4th quarter. ProShare Advisors LLC now owns 12,281 shares of the medical technology company's stock worth $2,186,000 after buying an additional 735 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Price Performance

Teleflex stock opened at $125.75 on Tuesday. The company's fifty day moving average price is $121.15 and its 200 day moving average price is $125.94. Teleflex Incorporated has a 1 year low of $108.90 and a 1 year high of $249.90. The stock has a market capitalization of $5.56 billion, a P/E ratio of 29.59, a P/E/G ratio of 1.82 and a beta of 1.08. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company had revenue of $780.90 million for the quarter, compared to analysts' expectations of $771.53 million. During the same quarter in the previous year, the company posted $3.42 EPS. The firm's quarterly revenue was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio is 32.00%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Royal Bank Of Canada raised their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research note on Friday, August 1st. Wells Fargo & Company reduced their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research note on Monday. Finally, Mizuho raised their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research note on Friday, August 1st. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $141.57.

Insider Activity at Teleflex

In other news, Director Jaewon Ryu bought 1,500 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the completion of the purchase, the director owned 3,727 shares of the company's stock, valued at approximately $428,605. This represents a 67.36% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stuart A. Randle bought 1,000 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The shares were purchased at an average price of $115.86 per share, for a total transaction of $115,860.00. Following the completion of the purchase, the director directly owned 7,547 shares of the company's stock, valued at approximately $874,395.42. This trade represents a 15.27% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders bought 5,500 shares of company stock valued at $633,590. 1.40% of the stock is owned by company insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.